Suppression of Behçet's disease with dapsone

Area of Science:

• Rheumatology and Immunology
• Dermatology

Background:

• Behçet's disease is a chronic inflammatory disorder.
• Pathergy is a characteristic hypersensitivity reaction in Behçet's disease.

Purpose of the Study:

• To evaluate the efficacy of dapsone in managing Behçet's disease.
• To assess the impact of dapsone on the pathergic reaction.

Main Methods:

• Seven male patients diagnosed with Behçet's disease were enrolled.
• Patients received a daily dosage of 100 mg of dapsone.
• The pathergic reaction was assessed using a deep needle-prick test.

Main Results:

• Dapsone treatment led to the suppression of the pathergic reaction in all patients.
• Significant symptomatic improvement was observed in patients receiving dapsone.
• The 100 mg daily dose of dapsone was well-tolerated.

Conclusions:

• Dapsone is a promising therapeutic agent for Behçet's disease.
• Dapsone effectively modulates the hypersensitivity response in Behçet's disease.
• Further research is warranted to confirm these findings in larger cohorts.